NanoSphere Health Sciences Inc. Stock: price and insider trades · Canada

NanoSphere Health Sciences Inc.: what insiders have been doing

This page follows insider dealings at NanoSphere Health Sciences Inc. as filed with SEDI, a company from the Health Care sector. NanoSphere Health Sciences Inc. has had no insider filing for more than a year; the last one goes back to 17 September 2021.

The full history, which starts in 2018, counts 3 purchases against no sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Insider Decl.

Thresholds

n/a

Buy Volume

€2,223

3 ops. · all time

Sell Volume

n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

CA$0.02

Analyst consensus

Income statement

EBITDA-CA$80.6k

Net income-CA$84.8k0.0% margin

Valuation

Beta1.05

Balance sheet & cash

Total debtCA$63.4k

Free Cash Flow-CA$23k

Profitability & ownership

ROA-637.6%

% insiders32.3%

% institutions0.0%

Last declaration on 17 September 2021

Declarations10 total

●

Toby Lim

4 - Director of IssuerExecutives17 Sept 2021

0SEDI

190,000 sharesCommon SharesTSXSEDI:3805070

●

Michael Alexander Iverson

4 - Director of IssuerExecutives17 Nov 2017

0SEDI

Common SharesTSXSEDI:3805108

●

Toby Lim

4 - Director of IssuerExecutives17 Nov 2017

0SEDI

Common SharesTSXSEDI:3805079

●

Toby Lim

4 - Director of IssuerExecutives17 Sept 2021

118,750 CAD19SEDI

625,000 shares@ CA$0.19100.0% of flowCommon SharesTSXSEDI:3805084

●

Michael Alexander Iverson

4 - Director of IssuerExecutives17 Sept 2021

128,803 CAD19SEDI

677,913 shares@ CA$0.19100.0% of flowCommon SharesTSXSEDI:3805126

●

Michael Alexander Iverson

4 - Director of IssuerExecutives8 Dec 2020

0SEDI

891,300 sharesCommon SharesTSXSEDI:3640657

●

David Sutton

4 - Director of IssuerExecutives7 Aug 2019

4,860 CAD19SEDI

27,000 shares@ CA$0.18100.0% of flowCommon SharesTSXSEDI:3406436

▲

Victor Goncalves

5 - Senior Officer of IssuerExecutives25 Apr 2018

1,680 CAD0SEDI

4,000 shares@ CA$0.42Common SharesTSXSEDI:3179468

Canonical exit: 24 Jul 2018 (T+90)

▲

Victor Goncalves

5 - Senior Officer of IssuerExecutives21 Feb 2018

203 CAD0SEDI

375 shares@ CA$0.54Common SharesTSXSEDI:3139046

Canonical exit: 22 May 2018 (T+90)

▲

Victor Goncalves

5 - Senior Officer of IssuerExecutives21 Feb 2018

1,590 CAD0SEDI

3,000 shares@ CA$0.53Common SharesTSXSEDI:3139042

Canonical exit: 22 May 2018 (T+90)

10 of 10 declarations

About NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. is a company focused on developing innovative health technologies. It concentrates on research and commercialization of solutions to enhance medical treatments.